Svizunate 60mg Injection
Marketer
Maneesh Pharmaceuticals Ltd
Salt Composition
Artesunate (60mg)
Overview Svizunate 60mg Injection
Malaria treatment utilizes the antiparasitic Svizunate 60mg Injection. This injectable medication is administered by a healthcare provider only and is unsuitable for malaria prevention or severe cases impacting vital organs (brain, lungs, kidneys). Oral administration is a prerequisite; injection is reserved for situations where this is infeasible. Common side effects include headache, dizziness, fatigue, and decreased appetite. Injection site reactions (pain, swelling, redness) are also possible. Persistent side effects warrant medical attention. Post-treatment, weekly blood tests for four weeks may be conducted to monitor parasite levels.
Primary Ingredients of Svizunate 60mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Svizunate 60mg Injection
Plasmodium infection
Major Benefits of Svizunate 60mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Svizunate 60mg Injection:
- Headache
- Dizziness
- Weakness
- Loss of appetite
- Injection site reactions (pain, swelling, redness)
How to use Svizunate 60mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Svizunate 60mg Injection works:
The antiparasitic drug, Svizunate 60mg Injection, eliminates the malaria parasite by generating cytotoxic free radicals within the parasite itself.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Svizunate 60mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Svizunate 60mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible adverse effects prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of a 60mg Svizunate injection while breastfeeding is likely safe. Available human data indicates minimal infant risk associated with the medication.
DrivingUNSAFE
The administration of Svizunate 60mg Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Svizunate 60mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Svizunate 60mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Svizunate 60mg Injection :
Omit doses of Svizunate 60mg Injection only after contacting your physician for guidance.
Facts to Know About Svizunate 60mg Injection
| Label | Value |
|---|---|
| Chemical Category | Sesquiterpene lactones |
| Developing Habits | No. |
| Treatment Category | Antimalarial Medications |
| Action Class | Artemisinin-based antimalarials |
3,018 People bought this recently